$76.01
+0.09 (+0.12%)
MGEE News3 articles
Amgen Shares Slide on FDA Setback and Enbrel Weakness, Pressuring Dow
Amgen stock fell nearly 2% Monday, pressured by an FDA request to withdraw rare-disease drug Tavneos and a sharp 48% quarterly drop in Enbrel sales. The decline weighed on the price-weighted Dow Jones Industrial Average.
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.
Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing
Amgen shares surged 4.5% to close at $384.32 on Friday, achieving a new 52-week high. Market participants are monitoring upcoming U.S. inflation figures and developments in drug pricing.